S
Shuo Wu
Researcher at Peking Union Medical College
Publications - 15
Citations - 344
Shuo Wu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Influenza A virus & Viral replication. The author has an hindex of 8, co-authored 15 publications receiving 214 citations.
Papers
More filters
Journal ArticleDOI
Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression.
TL;DR: The antiviral effect of luteolin against IAV and its novel antiviral mechanism is demonstrated and a time-of-addition assay indicated that this compound interfered with viral replication at the early stage of infection.
Journal ArticleDOI
Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy.
TL;DR: In this article, an isoquinoline alkaloid isolated from Berberis vulgaris L, has been reported to have ability to regulate the MEK-ERK signaling pathway and autophagy.
Journal ArticleDOI
Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway
Haiyan Yan,Hui-Qiang Wang,Linlin Ma,Linlin Ma,Xueping Ma,Jin-Qiu Yin,Shuo Wu,Hua Huang,Yu-Huan Li +8 more
TL;DR: Investigation of the anti-influenza virus efficacy and antiviral mechanism ofemisia scoparia Waldst and Kit finds it may be a potential agent or supplement against IAV infection.
Journal ArticleDOI
Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response
Linlin Ma,Hui-Qiang Wang,Ping Wu,Jin Hu,Jin-Qiu Yin,Shuo Wu,Miao Ge,Wen-Fang Sun,Jiangyu Zhao,Haji Akber Aisa,Yu-Huan Li,Jian-Dong Jiang +11 more
TL;DR: It is suggested that YZH-106 inhibits IAV by up-regulating HO-1-mediated IFN response, which is thus a promising host target for antiviral therapeutics against influenza and other viral infectious diseases.
Journal ArticleDOI
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Kai Lv,Zeyu Tao,Qian Liu,Lu Yang,Bin Wang,Shuo Wu,Apeng Wang,Menghao Huang,Mingliang Liu,Yu Lu +9 more
TL;DR: In this article, the design and synthesis of benzothiazinones containing a piperidine moiety as new antitubercular agents based on the structure feature of IMB-ZR-1 discovered in our lab was reported.